scholarly journals Non-invasive CMR-Based Quantification of Myocardial Power and Efficiency Under Stress and Ischemic Conditions in Landrace Pigs

2021 ◽  
Vol 8 ◽  
Author(s):  
Alessandro Faragli ◽  
Alessio Alogna ◽  
Chong Bin Lee ◽  
Miry Zhu ◽  
Niky Ghorbani ◽  
...  

Background: Myocardial efficiency should be maintained stable under light-to-moderate stress conditions, but ischemia puts the myocardium at risk for impaired functionality. Additionally, the measurement of such efficiency typically requires invasive heart catheterization and exposure to ionizing radiation. In this work, we aimed to non-invasively assess myocardial power and the resulting efficiency during pharmacological stress testing and ischemia induction.Methods: In a cohort of n = 10 healthy Landrace pigs, dobutamine stress testing was performed, followed by verapamil-induced ischemia alongside cardiac magnetic resonance (CMR) imaging. External myocardial power, internal myocardial power, and myocardial efficiency were assessed non-invasively using geometrical and functional parameters from CMR volumetric as well as blood flow and pressure measurements.Results: External myocardial power significantly increased under dobutamine stress [2.3 (1.6–3.1) W/m2 vs. 1.3 (1.1–1.6) W/m2, p = 0.005] and significantly decreased under verapamil-induced ischemia [0.8 (0.5–0.9) W/m2, p = 0.005]. Internal myocardial power [baseline: 5.9 (4.6–8.5) W/m2] was not affected by dobutamine [7.5 (6.9–9.0) W/m2, p = 0.241] nor verapamil [5.8 (4.7–8.8) W/m2, p = 0.878]. Myocardial efficiency did not change from baseline to dobutamine [21% (15–27) vs. 31% (20–44), p = 0.059] but decreased significantly during verapamil-induced ischemia [10% (8–13), p = 0.005].Conclusion: In healthy Landrace pigs, dobutamine stress increased external myocardial power, whereas myocardial efficiency was maintained stable. On the contrary, verapamil-induced ischemia substantially decreased external myocardial power and myocardial efficiency. Non-invasive CMR was able to quantify these efficiency losses and might be useful for future clinical studies evaluating the effects of therapeutic interventions on myocardial energetics.

1996 ◽  
Vol 78 (3) ◽  
pp. 340-343 ◽  
Author(s):  
Steven P Sedlis ◽  
Jeffrey Lorin ◽  
Albert Matalon ◽  
Suresh Chandrasekaran ◽  
Jeffrey Gold ◽  
...  

2004 ◽  
Vol 25 (4) ◽  
pp. 408 ◽  
Author(s):  
I. Jones ◽  
J. Thornley ◽  
A. Tukan ◽  
A. McCance

1994 ◽  
Vol 7 (3) ◽  
pp. 89-92
Author(s):  
Lisa B. Greenstein ◽  
John L. Hatch ◽  
Thomas P. Sherrin

Exercise electrocardiogram (ECG) testing in conjunction with radionuclide imaging provides prognostic, diagnostic, and important physiological information regarding the presence of ischemia. However, many patients cannot or will not exercise to 85% of maximal heart rate. When this occurs, potential disparities in regional myocardial perfusion may not be apparent. Pharmacological stress testing with intravenous (IV) dipyridamole provides an alternative method of increasing intracoronary blood flow in these patients and decreasing the incidence of suboptimal exercise myocardial perfusion scans. An ongoing program was begun in 1992 to determine the effect of using pharmacological stress testing with IV dipyridamole (in selected patients) on the incidence of suboptimal exercise myocardial perfusion scans. Myocardial perfusion scans from the months of February 1991 and February 1992 were reviewed. Data collected included demographic variables, heart rate, percent of maximum predicted heart rate, anti-anginal drug therapy, and any underlying conditions that could influence the patient's ability to exercise adequately. There was only a slight reduction in inadequate exercise tests between the two study periods, 30% in February 1991 and 23% in February 1992, without pharmacist intervention. There was an increase in the number of dipyridamole perfusion scans, one (<1%) in February 1991 and 10 (6%) in February 1992. These data were presented to physicians as part of an educational program on the availability and appropriate use of pharmacological stress testing with IV dipyridamole. Several suggestions were made to assist in decreasing the incidence of suboptimal exercise myocardial perfusion scans. The review was repeated in February 1993. There was a further increase in the number of dipyridamole perfusion scans (18, or 11% over previous levels); however, the rate of suboptimal exercise tests remained at 24%. This review offered an easy and unique opportunity for the pharmacy to be involved in multidisciplinary continuous quality improvement with nuclear medicine and cardiology. It is anticipated that with continued education and a change in patient screening procedures, along with the development and use of drug use guidelines, a decrease in the number of suboptimal exercise myocardial perfusion scans may be realized.


2008 ◽  
Vol 14 (6) ◽  
pp. S98
Author(s):  
Reynolds M. Delgado ◽  
Farshad Raissi Shabari ◽  
Biswajit Kar ◽  
Pranav Loyalka ◽  
Peggy Odegaard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document